Clinical Trials Browser

Phase 1/2 × NETWORK × AZD4547 × Clear all

NCT01824901 2023-06-29

Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer

Phase 1/2 Completed

2 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung